Newbridge Financial Services Group’s Cogent Biosciences COGT Stock Holding History

Newbridge Financial Services Group’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-122	Closed	-$1.19K	–	1196
2023 Q3	$1.19K	Hold	122	–	–	﹤0.01%	1137
2023 Q2	$1.44K	Hold	122	–	–	﹤0.01%	1176
2023 Q1	$1.32K	Hold	122	–	–	﹤0.01%	1252
2022 Q4	$1.41K	Hold	122	–	–	﹤0.01%	1268
2022 Q3	$2K	Hold	122	–	–	﹤0.01%	1183
2022 Q2	$1K	Hold	122	–	–	﹤0.01%	1257
2022 Q1	$1K	Hold	122	–	–	﹤0.01%	1361
2021 Q4	$1K	Hold	122	–	–	﹤0.01%	1307
2021 Q3	$1K	Hold	122	–	–	﹤0.01%	1239
2021 Q2	$1K	Hold	122	–	–	﹤0.01%	1339
2021 Q1	$1K	Buy	+122	New	+$1.18K	﹤0.01%	1246

Other funds holding COGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Newbridge Financial Services Group's COGT Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Cogent Biosciences (COGT) in Q4 2023, closing a stake of 122 shares — an estimated $1.19K sold.

Newbridge Financial Services Group first reported a position in COGT in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q3 2022. 144 funds tracked by Wall St. Rank hold COGT as of Q4 2023.

Newbridge Financial Services Group reported no remaining Cogent Biosciences position as of Q4 2023 after selling out during the quarter.
Newbridge Financial Services Group sold 122 Cogent Biosciences shares in Q4 2023, an estimated $1.19K.
Newbridge Financial Services Group first reported a position in Cogent Biosciences in Q1 2021 and held it in 11 quarters.
Newbridge Financial Services Group's Cogent Biosciences position peaked at $2K in Q3 2022.
144 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.